Enveric Biosciences begins genotoxicity studies for EB-003 drug candidate
Go back to Enveric Biosciences begins genotoxicity studies for EB-003 drug candidate| (NASDAQ: ENVB) | Delayed: 1.32 -0.02 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.34 | 52 Week High | $ | |||
| Open | $1.31 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $ | |||
| Volume | 118,610 | |||||
